(Q38306649)

2 September 2017

Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells (English)

1 reference

2 September 2017

Iotti G

1

1 reference

2 September 2017

Ferrari-Amorotti G

2

1 reference

2 September 2017

Rosafio C

3

1 reference

2 September 2017

Corradini F

4

1 reference

2 September 2017

Lidonnici MR

5

1 reference

2 September 2017

Ronchetti M

6

1 reference

2 September 2017

Bardini M

7

1 reference

2 September 2017

Zhang Y

8

1 reference

2 September 2017

Martinez R

9

1 reference

2 September 2017

Blasi F

10

1 reference

2 September 2017

Calabretta B

11

1 reference

2 September 2017

language of work or name

English

0 references

publication date

11 December 2006

1 reference

2 September 2017

1 reference

2 September 2017

26

1 reference

2 September 2017

24

1 reference

2 September 2017

3482-3491

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210146

2 September 2017

0 references

cites work

Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Proteolytic activation of alternative CCR1 ligands in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Regulation of both apoptosis and cell survival by the v-Src oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBP alpha and C/EBP epsilon ) and CDP/cut in myeloid maturation-induced lactoferrin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Molecular mechanisms of transformation by the BCR-ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

inferred from DOI database lookup

7 January 2021

based on heuristic

CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

inferred from DOI database lookup

7 January 2021

based on heuristic

Presence of P210bcrabl is associated with decreased expression of a beta chemokine C10 gene in a P210bcrabl-positive myeloid leukemia cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210146

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210146

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference